Towards an experimental and systems biology framework for cancer cell therapeutics

Current Bioinformatics

Volumn 7, Issue 4, 2012, Pages 490-504

  Mitrasinovic, Petar M ^a  

^a Belgrade Institute of Science and Technology   (Serbia)

Author keywords

Apoptosis; Cancer cell therapeutics; Modular cell biology; Molecular cell biology; Signal transmission; Systems biology

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CELL SIGNALING; DISEASES;

CANCER CELL THERAPEUTIC; CANCER CELLS; CELL BIOLOGY; MODULAR CELL BIOLOGY; MODULAR CELLS; MOLECULAR CELL BIOLOGY; MOLECULAR CELLS; SIGNAL TRANSMISSION; SYSTEMS BIOLOGY;

CELL DEATH;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

CANCER CELL; CELL DEATH; CELL SURVIVAL; CYTOLOGY; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 84874902190     PISSN: 15748936     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489312803901072     Document Type: Review

References (71)

1. Mitrasinovic PM. Origin of oscillations in molecular mechanism of radioresistance of prostate carcinoma cells: implications for successful therapy. Cancer Res J 2009; 3(1/2): 85-118.
2. Mitrasinovic PM. In: Handbook of Prostate Cancer Cell Research: Growth, Signaling and Survival, Meridith AT, Ed. Nova Science Publishers Inc.: New York 2009; pp. 273-302.
3. Mitrasinovic PM. Cross-linking between thymine and indolyl radical: possible mechanisms for cross-linking of DNA and tryptophan-containing peptides. Bioconjugate Chem 2005; 6: 588-97.
4. Sansom C. Systems biology: will it work? IEE Proc Syst Biol 2005; 2: 1-4.
5. Mesarovic MD, Sreenath SN, Keene JD. Search for organizing principles: understanding in systems biology. IEE Proc Syst Biol 2004; 1: 19-27.
6. Sontag ED. Some new directions in control theory inspired by systems biology. IEE Proc Syst Biol 2004; 1: 9-18.
7. Wigle D, Jurisica I. Cancer as a system failure. Cancer Inform 2007; 2: 10-8.
8. Kitano H. Systems biology: a brief overview. Science 2002; 295: 1662-4.
9. Sakaki Y, Kholodenko BN, Hatakeyama M, et al. International consortium on systems biology of receptor tyrosine kinase regulatory networks. IEE Proc Syst Biol 2005; 152: 53-60.
10. Mitrasinovic PM, Mitrasinovic O. On possible mechanisms for reactive oxygen species (ROS)-mediated cross-talk between NF-B and JNK: a systems biology view. GESTS Intl Trans Comput Sci Engr 2006; 27: 41-52.
11. Mitrasinovic PM, Mihajlovic ML. Recent advances in radiation therapy of cancer cells: a step towards an experimental and systems biology framework. Curr Radiopharm 2008; 1: 22-9.
12. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002, 296: 1634-5.
13. Schweichel JU, Merker HJ. The morphology of various types of cell death in prenatal tissues. Teratology 1973; 7: 253-66.
14. Fiers W, Beyaert R, Declercq W, Vandenabeele P. More than one way to die: apoptosis, necrosis and reactive oxygen damage. Oncogene 1999; 18: 7719-30.
15. Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Differ 1999, 6: 508-15.
16. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000; 103: 239-52.
17. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature (Supp) 1999; 402: C47-52.
18. Freeman BC, Yamamoto KR. Continuous recycling: a mechanism for modulatory signal transduction. Trends Biochem Sci 2001; 26: 285-90.
19. Pham CG, Bubici C, Zazzeroni F, et al. Ferritin heavy chain upregulation by NF-B inhibits TNF -induced apoptosis by suppressing reactive oxygen species. Cell 2004; 119: 529-42.
20. Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods 2002; 265: 49-72.
21. Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. BioEssays 2002; 25: 17-24.
22. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNF -induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005; 120: 649-61.
23. Ihekwaba AEC, Broomhead DS, Grimley RL, Benson N, Kell DB. Sensitivity analysis of parameters controlling oscillatory signaling in the NF-B pathway: the roles of IKK and I B. Syst Biol 2004; 1: 93-103.
24. Kholodenko BN. Negative feedback and ultrasensitivity can bring about oscillations in the mitogen-activated protein kinase cascades. Eur J Biochem 2000; 267: 1583-8.
25. Hoffmann A., Levchenko A, Scott ML, Baltimore D. The I B-NF-B signaling module: temporal control and selective gene activation. Science 2002; 298: 1241-5.
26. Neves SR, Iyengar R. Modeling of signaling networks. BioEssays 2002; 24: 1110-7.
27. Mendes P, Kell D. Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics 1998; 14: 869-83.
28. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular single-regulated kinase activation. Cell 1995; 80: 179-85.
29. Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving stability of lipopolysaccharide-induced NF-B activation. Science 2005; 309: 1854-7.
30. Werner SL, Barken D, Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 2005; 309: 1857-61.
31. Ferrel JE Jr, Machleder EM. The biochemical basis of an all-or-none cell fate switch in Xenopus Oocytes. Science 1998; 280: 895-8.
32. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2002; 52: 23-47.
33. Lucia MS, Darke AK, Goodman PJ, et al. Pathologic characteristics of cancers detected in the prostate cancer prevention trial: implications for prostate cancer detection and chemoprevention. Cancer Preven Res 2008; 1: 167-73.
34. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA Cancer J Clin 2008; 58: 71-96.
35. Zagars GK, Pollack A, Smith LG. Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3, NX/N0, M0) adenocarcinoma of the prostate. Int J Radiation Oncol Biol Phys 1999; 44: 809-19.
36. Kaplan ID, Cox RS, Bagshaw MA. Prostate specific antigen after external beam radiotherapy for prostatic cancer: follow-up. J Urol 1993; 149: 519-22.
37. Shukla S, MacLennan GT, Fu P, et al. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 2004; 6: 390-400.
38. Lin A, Karin M. NF-kappaB in cancer: a marked target. Semin Cancer Biol 2003; 13: 107-14.
39. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-B and activated protein-1. J Biol Chem 1998; 273: 13245-54.
40. Kim HT, Kim YH, Nam JW, Lee HJ, Rho HM, Jung G. Study of 5'-flanking region of human Cu/Zn superoxide dismutase. Biochem Biophys Res Commun 1994, 201: 1526-33.
41. Xu Y, Kiningham KK, Devalaraja MN, et al. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol 1999; 18: 709-22.
42. Zhou LZ, Johnson AP, Rando TA. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic Biol Med 2001; 31: 1405-16.
43. Jung K, Seidel B, Rudolph B, Lein M, Cronauer MV, Henke W, Hampel G, Schnorr D, Loening SA. Antioxidant enzymes in malignant prostate cell lines and in primary cultured prostatic cells. Free Radic Biol Med 1997; 23: 127-33.
44. Oberley TD, Zhong W, Szweda LI, Oberley LW. Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 2000; 44: 144-55.
45. Gajewska J, Szczypka M, Izbicki T, Klepacka T, Laskowska-Klita T. Antioxidant and glutathione-associated enzymes in Wilms' tumor after chemotherapy. J Cancer Res Clin Oncol 1996; 122: 483-8.
46. Chen QM, Liu J, Merrett JB. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human. Biochem J 2000; 347: 543-51.
47. Niciforovic A, Djordjevic J, Adzic M, Vucic V, Mitrasinovic PM, Radojcic MB. Experimental and systems biology studies of the molecular basis for the radioresistance of prostate carcinoma cells. Ann Biomed Eng 2008; 36: 831-8.
48. Mitrasinovic PM. Systems biology studies of reactive oxygen species (ROS)-mediated apoptosis. In: Anic S, Ed. PHYSCHEM 2006. Proceedings of the 8th International Conference on Fundamental and Applied Aspects of Physical Chemistry; 2006 Sep 26-29; Belgrade, Serbia 2006; pp. 279-81.
49. Isaacs WB, Carter BS, Ewing CM. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 1991; 51: 4716-20.
50. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 2006; 6: 107-7.
51. Vucic V, Isenovic ER, Adzic M, Ruzdijic S, Radojcic MB. Effects of gamma-radiation on cell growth, cycle arrest, death, and superoxide dismutase expression by DU 145 human prostate cancer cells. Braz J Med Biol Res 2006; 39: 227-36.
52. Joiner MC, Marples B, Forman JD, Sarkar FH. Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther 2004; 3: 1271-9.
53. Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59: 928-42.
54. Sweeney C, Li L, Shanmugam R, et al. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin Cancer Res 2004; 10: 5501-7.
55. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-500.
56. Lim SD, Sun C, Lambeth JD, Marshall F, et al. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 2005; 62: 200-7.
57. Roninson IB. Tumor senescence as a determinant of drug response in vivo. Drug Resist. Updat 2002; 5: 204-8.
58. Barnouin K, Dubuisson ML, Child ES, et al. H2O2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. J Biol Chem 2002; 277: 13761-70.
59. Li S, Yan T, Yang JQ, Oberley TD, Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 2000; 60: 3927-39.
60. Rhee S, Bae Y, Lee S-R, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000; 53: PE1-1.
61. Bernard D, Monte D, Vandenbunder B, Abbadie C. The c-Rel transcription factor can both induce and inhibit apoptosis in the same cells via the upregulation of MnSOD. Oncogene 2002; 21: 4392-402.
62. Wang CY, Mayo MW, Baldwin AS Jr. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996; 274: 784-7.
63. Buettner GR, Ng F, Chin M, Wang V, Rodgers GJ, Schafer FQ. A new paradigm: manganese superoxide dismutase influences the production of H2O2 in cells and thereby their biological state. Free Radic Biol Med 2006; 41: 1338-50.
64. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-B and activated protein-1. J Biol Chem 1998; 273: 13245-54.
65. Pajonk F, Pajonk K, McBride WH. Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells. J Natl Cancer Inst 1999; 91: 1956-60.
66. Fersht A. Enzyme Structure and Mechanism. 1st Ed. WH Freeman and Company: New York 1998, p. 475.
67. Vilenchik MM, Knudson AG Jr. Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage. Proc Natl Acad Sci USA 2000; 97: 5381-6.
68. Shi X, Dong Z, Huang C, et al. The role of hydroxyl radical as a messenger in the activation of nuclear transcription factor NF-kappaB. Mol Cell Biochem 1999; 194: 63-70.
69. Mitrasinovic PM. Origin of oscillation in molecular mechanism of radioresitance of prostate carcinoma cells. In: Anic S, Ed. PHYSCHEM 2008. Proceedings of the 9th International Conference on Fundamental and Applied Aspects of Physical Chemistry; 2008 Sep 24-26; Belgrade, Serbia 2008; pp. 373-5.
70. Guo G, Yan-Sanders Y, Lyn-Cook BD, et al. Manganese superoxide dismutase-mediated gene expression in radiation induced adaptive responses. Mol Cell Biol 2003; 23: 2362-78.
71. Huang TT, Yasunami M, Carlson EJ, et al. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch Biochem Biophys 1997; 344: 424-32.